Stay updated on MAXDARA Clinical Trial
Sign up to get notified when there's something new on the MAXDARA Clinical Trial page.

Latest updates to the MAXDARA Clinical Trial page
- Check4 days agoChange DetectedThe page shows the same study details with only minor formatting and wording changes; there are no changes to core data such as interventions, inclusion/exclusion criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

- Check40 days agoChange Detected- Updated the page revision from v3.0.2 to v3.1.0. - Replaced the term 'Plasma cell myeloma' with 'Multiple myeloma' and added new contact details (phone numbers and email).SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.0.2 added; previous v3.0.1 removed, and the 'Back to Top' element was deleted.SummaryDifference0.1%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check69 days agoChange DetectedThe web page has been updated to include specific facility names and locations related to plasma cell myeloma, while removing previous references to certain locations and drug information.SummaryDifference4%

Stay in the know with updates to MAXDARA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAXDARA Clinical Trial page.